259 related articles for article (PubMed ID: 16532019)
1. Unrelated bone marrow transplantation using a reduced intensity-conditioning regimen in leukocyte adhesion deficiency.
Takahashi D; Nagatoshi Y; Saito Y; Inagaki J; Nagayama J; Shinkoda Y; Fujita K; Okamura J
Bone Marrow Transplant; 2006 Apr; 37(8):807-8. PubMed ID: 16532019
[No Abstract] [Full Text] [Related]
2. Matched unrelated bone marrow transplantation with reduced-intensity conditioning for leukocyte adhesion deficiency.
Engel ME; Hickstein DD; Bauer TR; Calder C; Manes B; Frangoul H
Bone Marrow Transplant; 2006 Apr; 37(7):717-8. PubMed ID: 16489359
[No Abstract] [Full Text] [Related]
3. Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial.
Markova M; Barker JN; Miller JS; Arora M; Wagner JE; Burns LJ; MacMillan ML; Douek D; DeFor T; Tan Y; Repka T; Blazar BR; Weisdorf DJ
Bone Marrow Transplant; 2007 Feb; 39(4):193-9. PubMed ID: 17220905
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
[TBL] [Abstract][Full Text] [Related]
6. Risk assessment in haematopoietic stem cell transplantation: stem cell source.
Urbano-Ispizua A
Best Pract Res Clin Haematol; 2007 Jun; 20(2):265-80. PubMed ID: 17448961
[TBL] [Abstract][Full Text] [Related]
7. Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis.
Kröger N; Thiele J; Zander A; Schwerdtfeger R; Kobbe G; Bornhäuser M; Bethge W; Schubert J; de Witte T; Kvasnicka HM;
Exp Hematol; 2007 Nov; 35(11):1719-22. PubMed ID: 17976523
[TBL] [Abstract][Full Text] [Related]
8. CD34 stem cell top-ups without conditioning after initial haematopoietic stem cell transplantation for correction of incomplete haematopoietic and immunological recovery in severe congenital immunodeficiencies.
Booth C; Ribeil JA; Audat F; Dal-Cortivo L; Veys PA; Thrasher AJ; Davies EG; Lefrère F; Fischer A; Cavazzana-Calvo M; Gaspar HB
Br J Haematol; 2006 Nov; 135(4):533-7. PubMed ID: 17054675
[TBL] [Abstract][Full Text] [Related]
9. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
10. [Bone marrow transplantation in the primary immunodeficiencies].
Madero López L; Villa Alcázar M
Sangre (Barc); 1999 Apr; 44(2):135-41. PubMed ID: 10382323
[No Abstract] [Full Text] [Related]
11. Acute graft-versus-host disease: differing risk with differing graft sources and conditioning intensity.
Johnston L
Best Pract Res Clin Haematol; 2008 Jun; 21(2):177-92. PubMed ID: 18503985
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
[TBL] [Abstract][Full Text] [Related]
13. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
14. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L
Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547
[TBL] [Abstract][Full Text] [Related]
15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
16. Matched unrelated donor bone marrow transplantation in leukocyte adhesion deficiency.
Mancias C; Infante AJ; Kamani NR
Bone Marrow Transplant; 1999 Dec; 24(11):1261-3. PubMed ID: 10642820
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic hematopoietic stem cell transplantation using a reduced-intensity conditioning regimen in infants: experience at a single institution in Mexico.
Llano OG; Perez JC; Rodriguez OC; Guerra CM; Aguirre HG; Garza JL; Rodriguez-Romo L; Almaguer DG
Pediatr Hematol Oncol; 2008; 25(1):39-47. PubMed ID: 18231953
[TBL] [Abstract][Full Text] [Related]
18. Durable remission of Sézary syndrome after unrelated bone marrow transplantation by reduced-intensity conditioning.
Kahata K; Hashino S; Takahata M; Fujisawa F; Kondo T; Kobayashi S; Fujita Y; Shimizu H; Imamura M; Asaka M
Acta Haematol; 2008; 120(1):14-8. PubMed ID: 18716396
[TBL] [Abstract][Full Text] [Related]
19. [Allogeneic bone marrow transplantation with a nonmyeloablative conditioning regimen in a patient with acute myeloblastic leukemia].
Rossiev VA; Aleksandrova IIa; Lipshina SR; Stukalova TA; Savchenko VG
Ter Arkh; 2000; 72(7):67. PubMed ID: 10983326
[No Abstract] [Full Text] [Related]
20. Results of genoidentical hemopoietic stem cell transplantation with reduced intensity conditioning for acute myelocytic leukemia: higher doses of stem cells infused benefit patients receiving transplants in second remission or beyond--the Acute Leukemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation.
Gorin NC; Labopin M; Boiron JM; Theorin N; Littlewood T; Slavin S; Greinix H; Cahn JY; Alessandrino EP; Rambaldi A; Nagler A; Polge E; Rocha V;
J Clin Oncol; 2006 Aug; 24(24):3959-66. PubMed ID: 16880451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
